$5.11 Billion is the total value of Eventide Asset Management's 142 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 32.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $263,864,000 | +4.3% | 1,709,848 | 0.0% | 5.16% | -6.0% | |
| EXAS | EXACT SCIENCES CORP | $177,393,000 | +17.3% | 1,740,000 | 0.0% | 3.47% | +5.6% | |
| W | Buy | WAYFAIR INCcl a | $167,675,000 | +48.1% | 576,184 | +0.6% | 3.28% | +33.4% |
| TTD | Buy | THE TRADE DESK INC | $156,404,000 | +28.3% | 301,484 | +0.5% | 3.06% | +15.5% |
| FIVN | Buy | FIVE9 INC | $150,304,000 | +18.0% | 1,159,035 | +0.7% | 2.94% | +6.2% |
| CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $136,583,000 | +38.0% | 994,635 | +0.8% | 2.67% | +24.3% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $130,812,000 | -18.1% | 931,512 | -6.5% | 2.56% | -26.2% |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $115,962,000 | -11.1% | 1,783,761 | 0.0% | 2.27% | -19.9% | |
| IGV | Sell | ISHARES TRput | $112,500,000 | -18.3% | 480,000 | -20.0% | 2.20% | -26.4% |
| DT | Buy | DYNATRACE INC | $108,500,000 | +44.5% | 2,645,050 | +43.0% | 2.12% | +30.1% |
| ROP | Buy | ROPER TECHNOLOGIES INC | $100,042,000 | +10.9% | 253,200 | +9.0% | 1.96% | -0.2% |
| TWLO | Buy | TWILIO INCcl a | $95,870,000 | +13.2% | 387,997 | +0.5% | 1.88% | +2.0% |
| MTD | METTLER TOLEDO INTERNATIONAL | $87,883,000 | +19.9% | 91,000 | 0.0% | 1.72% | +7.9% | |
| LOW | Sell | LOWES COS INC | $85,302,000 | +5.2% | 514,300 | -14.3% | 1.67% | -5.2% |
| MYOK | MYOKARDIA INC | $84,661,000 | +41.1% | 621,000 | 0.0% | 1.66% | +27.1% | |
| POOL | Buy | POOL CORP | $83,568,000 | +23.3% | 249,800 | +0.2% | 1.64% | +11.1% |
| WCN | WASTE CONNECTIONS INC | $83,455,000 | +10.7% | 804,000 | 0.0% | 1.63% | -0.3% | |
| IDXX | Buy | IDEXX LABS INC | $79,015,000 | +36.0% | 201,000 | +14.2% | 1.55% | +22.5% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $76,455,000 | +18.5% | 1,275,100 | +1.4% | 1.50% | +6.8% |
| FVRR | Buy | FIVERR INTL LTD | $71,838,000 | +144.3% | 516,893 | +29.8% | 1.41% | +120.0% |
| TT | Buy | TRANE TECHNOLOGIES PLC | $71,538,000 | +70.3% | 590,000 | +25.0% | 1.40% | +53.3% |
| KRTX | KARUNA THERAPEUTICS INC | $69,671,000 | -30.6% | 901,077 | 0.0% | 1.36% | -37.5% | |
| HUBS | Buy | HUBSPOT INC | $68,870,000 | +32.3% | 235,672 | +1.6% | 1.35% | +19.2% |
| LRCX | Buy | LAM RESEARCH CORP | $66,949,000 | +3.0% | 201,806 | +0.4% | 1.31% | -7.2% |
| ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $64,516,000 | +22.6% | 356,600 | +15.0% | 1.26% | +10.4% |
| ASML | ASML HOLDING N V | $63,514,000 | +0.3% | 172,000 | 0.0% | 1.24% | -9.7% | |
| TREX | Buy | TREX CO INC | $63,151,000 | +29.8% | 882,000 | +135.8% | 1.24% | +16.9% |
| VRSK | Buy | VERISK ANALYTICS INC | $61,782,000 | +65.4% | 333,400 | +51.9% | 1.21% | +48.9% |
| PLRX | PLIANT THERAPEUTICS INC | $61,693,000 | -30.2% | 2,838,125 | 0.0% | 1.21% | -37.1% | |
| DHI | Sell | D R HORTON INC | $54,423,000 | +34.4% | 719,600 | -1.5% | 1.06% | +21.0% |
| ANNX | New | ANNEXON INC | $52,395,000 | – | 1,773,111 | +100.0% | 1.03% | – |
| IPHI | Buy | INPHI CORP | $51,004,000 | -3.5% | 454,378 | +1.0% | 1.00% | -13.1% |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $50,550,000 | +19.0% | 2,427,976 | 0.0% | 0.99% | +7.1% | |
| MRTX | MIRATI THERAPEUTICS INC | $49,981,000 | +45.4% | 301,000 | 0.0% | 0.98% | +30.9% | |
| APTV | APTIV PLC | $49,232,000 | +17.7% | 537,000 | 0.0% | 0.96% | +5.9% | |
| BEP | Sell | BROOKFIELD RENEWABLE PARTNERpartnership unit | $46,628,000 | +6.2% | 887,300 | -3.2% | 0.91% | -4.3% |
| ECL | New | ECOLAB INC | $45,963,000 | – | 230,000 | +100.0% | 0.90% | – |
| Buy | TRILLIUM THERAPEUTICS INC | $45,429,000 | +120.5% | 3,197,008 | +25.5% | 0.89% | +98.4% | |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $45,171,000 | +2.5% | 271,300 | +3.0% | 0.88% | -7.7% |
| ZI | New | ZOOMINFO TECHNOLOGIES INC | $44,882,000 | – | 1,044,018 | +100.0% | 0.88% | – |
| CTAS | New | CINTAS CORP | $44,266,000 | – | 133,000 | +100.0% | 0.87% | – |
| RNG | Buy | RINGCENTRAL INCcl a | $43,759,000 | -0.9% | 159,349 | +2.8% | 0.86% | -10.7% |
| BPMC | BLUEPRINT MEDICINES CORP | $42,827,000 | +18.8% | 462,000 | 0.0% | 0.84% | +7.0% | |
| GWPH | GW PHARMACEUTICALS PLCads | $42,445,000 | -20.7% | 436,000 | 0.0% | 0.83% | -28.5% | |
| ARGX | Sell | ARGENX SEsponsored adr | $42,003,000 | -29.4% | 160,000 | -39.4% | 0.82% | -36.4% |
| SPT | New | SPROUT SOCIAL INC | $37,730,000 | – | 980,007 | +100.0% | 0.74% | – |
| MGA | Buy | MAGNA INTL INC | $36,284,000 | +10.9% | 793,100 | +7.9% | 0.71% | -0.1% |
| FRLN | New | FREELINE THERAPEUTICS HLDGSsponsored ads added | $35,620,000 | – | 2,343,304 | +100.0% | 0.70% | – |
| PANW | Buy | PALO ALTO NETWORKS INC | $35,563,000 | +9.2% | 145,302 | +2.4% | 0.70% | -1.7% |
| RCKT | ROCKET PHARMACEUTICALS INC | $35,433,000 | +9.2% | 1,550,000 | 0.0% | 0.69% | -1.6% | |
| HASI | Sell | HANNON ARMSTRONG SUST INFR C | $34,953,000 | +46.4% | 826,900 | -1.5% | 0.68% | +31.8% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $34,637,000 | -20.7% | 360,200 | +0.7% | 0.68% | -28.6% |
| DDOG | Buy | DATADOG INC | $34,258,000 | +19.8% | 335,335 | +1.9% | 0.67% | +7.9% |
| SPLK | Sell | SPLUNK INC | $34,096,000 | -54.8% | 181,237 | -52.3% | 0.67% | -59.4% |
| TPTX | TURNING POINT THERAPEUTICS I | $33,459,000 | +35.3% | 383,000 | 0.0% | 0.66% | +21.7% | |
| IMVT | Buy | IMMUNOVANT INC | $32,797,000 | +115.2% | 932,000 | +48.9% | 0.64% | +94.0% |
| VCYT | VERACYTE INC | $30,216,000 | +25.4% | 930,000 | 0.0% | 0.59% | +12.8% | |
| NOVT | Buy | NOVANTA INC | $29,758,000 | -0.5% | 282,492 | +0.9% | 0.58% | -10.3% |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $29,500,000 | -12.7% | 535,000 | 0.0% | 0.58% | -21.4% | |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $28,822,000 | -32.2% | 911,416 | -0.4% | 0.56% | -39.0% |
| ROL | Sell | ROLLINS INC | $26,282,000 | -3.0% | 485,000 | -24.1% | 0.51% | -12.7% |
| KALA | KALA PHARMACEUTICALS INC | $25,875,000 | -28.6% | 3,450,000 | 0.0% | 0.51% | -35.7% | |
| LII | Sell | LENNOX INTL INC | $25,898,000 | -56.4% | 95,000 | -62.7% | 0.51% | -60.8% |
| VMC | Sell | VULCAN MATLS CO | $25,346,000 | -45.1% | 187,000 | -53.1% | 0.50% | -50.5% |
| AVRO | AVROBIO INC | $24,807,000 | -25.4% | 1,905,307 | 0.0% | 0.49% | -32.8% | |
| CGNX | COGNEX CORP | $23,371,000 | +9.0% | 359,000 | 0.0% | 0.46% | -1.9% | |
| OKTA | OKTA INCcl a | $23,096,000 | +6.8% | 108,000 | 0.0% | 0.45% | -3.8% | |
| SWKS | Buy | SKYWORKS SOLUTIONS INC | $22,986,000 | +21.3% | 157,977 | +6.6% | 0.45% | +9.2% |
| SMAR | Sell | SMARTSHEET INC | $21,597,000 | -61.9% | 437,000 | -60.7% | 0.42% | -65.7% |
| KALV | KALVISTA PHARMACEUTICALS INC | $21,151,000 | +4.0% | 1,680,000 | 0.0% | 0.41% | -6.3% | |
| CRNX | CRINETICS PHARMACEUTICALS IN | $21,107,000 | -10.6% | 1,347,000 | 0.0% | 0.41% | -19.5% | |
| AY | ATLANTICA SUSTAINABLE INFR P | $21,057,000 | -1.7% | 736,000 | 0.0% | 0.41% | -11.6% | |
| MDB | Buy | MONGODB INCcl a | $20,326,000 | +4.4% | 87,797 | +2.1% | 0.40% | -5.9% |
| SGEN | SEATTLE GENETICS INC | $20,058,000 | +15.2% | 102,500 | 0.0% | 0.39% | +3.7% | |
| STRO | SUTRO BIOPHARMA INC | $19,959,000 | +29.5% | 1,985,975 | 0.0% | 0.39% | +16.7% | |
| MPWR | New | MONOLITHIC PWR SYS INC | $19,845,000 | – | 70,975 | +100.0% | 0.39% | – |
| ADCT | Buy | ADC THERAPEUTICS SA | $19,150,000 | +172.8% | 580,483 | +287.0% | 0.38% | +145.1% |
| XPO | XPO LOGISTICS INC | $18,625,000 | +9.6% | 220,000 | 0.0% | 0.36% | -1.1% | |
| ISRG | INTUITIVE SURGICAL INC | $17,739,000 | +24.5% | 25,000 | 0.0% | 0.35% | +11.9% | |
| RGEN | REPLIGEN CORP | $17,557,000 | +19.4% | 119,000 | 0.0% | 0.34% | +7.5% | |
| NRIX | New | NURIX THERAPEUTICS INC | $17,376,000 | – | 497,740 | +100.0% | 0.34% | – |
| ETNB | Buy | 89BIO INC | $17,321,000 | +51.1% | 675,000 | +17.4% | 0.34% | +36.1% |
| REGN | REGENERON PHARMACEUTICALS | $17,297,000 | -10.2% | 30,900 | 0.0% | 0.34% | -19.1% | |
| BEPC | New | BROOKFIELD RENEWABLE CORPcl a sub vtg added | $16,712,000 | – | 285,200 | +100.0% | 0.33% | – |
| PHAT | PHATHOM PHARMACEUTICALS INC | $16,502,000 | +11.4% | 450,000 | 0.0% | 0.32% | +0.3% | |
| CCXI | Buy | CHEMOCENTRYX INC | $16,276,000 | +61.6% | 297,000 | +69.7% | 0.32% | +45.7% |
| JAMF | New | JAMF HLDG CORP | $16,172,000 | – | 430,000 | +100.0% | 0.32% | – |
| XLRN | ACCELERON PHARMA INC | $16,081,000 | +18.1% | 142,900 | 0.0% | 0.32% | +6.4% | |
| MGTA | MAGENTA THERAPEUTICS INC | $16,046,000 | -9.5% | 2,359,646 | 0.0% | 0.31% | -18.4% | |
| EIDX | Buy | EIDOS THERAPEUTICS INC | $16,039,000 | +58.0% | 317,417 | +49.0% | 0.31% | +42.1% |
| EPIX | Buy | ESSA PHARMA INC | $15,307,000 | +29.3% | 2,335,169 | +16.2% | 0.30% | +16.7% |
| XENE | XENON PHARMACEUTICALS INC | $14,104,000 | -11.7% | 1,274,100 | 0.0% | 0.28% | -20.5% | |
| LW | Sell | LAMB WESTON HLDGS INC | $13,453,000 | +0.9% | 203,000 | -2.7% | 0.26% | -9.3% |
| ALLK | ALLAKOS INC | $13,032,000 | +13.3% | 160,000 | 0.0% | 0.26% | +2.0% | |
| CHMA | Buy | CHIASMA INC | $12,901,000 | +148.8% | 3,000,326 | +211.2% | 0.25% | +123.9% |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $12,466,000 | -14.1% | 243,000 | 0.0% | 0.24% | -22.5% | |
| KURA | New | KURA ONCOLOGY INC | $12,256,000 | – | 400,000 | +100.0% | 0.24% | – |
| MKC | Buy | MCCORMICK & CO INC | $12,151,000 | +12.9% | 62,600 | +4.3% | 0.24% | +1.7% |
| XNCR | XENCOR INC | $11,637,000 | +19.8% | 300,000 | 0.0% | 0.23% | +8.1% | |
| RLAY | New | RELAY THERAPEUTICS INC | $10,648,000 | – | 250,000 | +100.0% | 0.21% | – |
| CIEN | CIENA CORP | $10,597,000 | -26.7% | 267,000 | 0.0% | 0.21% | -34.1% | |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $10,320,000 | +41.4% | 699,200 | +42.0% | 0.20% | +27.0% |
| IMTX | New | IMMATICS N.V | $8,488,000 | – | 800,000 | +100.0% | 0.17% | – |
| PLD | Buy | PROLOGIS INC. | $7,697,000 | +63.0% | 76,500 | +51.2% | 0.15% | +46.6% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $7,507,000 | +24.6% | 506,179 | +9.2% | 0.15% | +12.2% |
| A | Buy | AGILENT TECHNOLOGIES INC | $7,409,000 | +28.2% | 73,400 | +12.2% | 0.14% | +15.1% |
| GLPG | GALAPAGOS NVspon adr | $7,237,000 | -28.1% | 51,000 | 0.0% | 0.14% | -35.2% | |
| FENC | FENNEC PHARMACEUTICALS INC | $6,787,000 | -27.4% | 1,120,000 | 0.0% | 0.13% | -34.5% | |
| ITT | Buy | ITT INC | $5,982,000 | +63.7% | 101,300 | +62.9% | 0.12% | +48.1% |
| ARE | Buy | ALEXANDRIA REAL ESTATE EQ IN | $5,936,000 | +10.2% | 37,100 | +11.7% | 0.12% | -0.9% |
| ARVN | ARVINAS INC | $5,430,000 | -29.6% | 230,000 | 0.0% | 0.11% | -36.9% | |
| STE | Buy | STERIS PLC | $5,145,000 | +74.6% | 29,200 | +52.1% | 0.10% | +57.8% |
| NEE | Sell | NEXTERA ENERGY INC | $5,135,000 | +11.9% | 18,500 | -3.1% | 0.10% | +1.0% |
| ENTG | Buy | ENTEGRIS INC | $4,391,000 | +420.3% | 59,061 | +313.0% | 0.09% | +377.8% |
| KLAC | Buy | KLA CORP | $4,335,000 | +66.3% | 22,374 | +67.0% | 0.08% | +49.1% |
| FRC | Buy | FIRST REP BK SAN FRANCISCO C | $4,275,000 | +25.3% | 39,200 | +21.7% | 0.08% | +13.5% |
| JKHY | Buy | HENRY JACK & ASSOC INC | $4,309,000 | -3.6% | 26,500 | +9.1% | 0.08% | -13.4% |
| AWK | Buy | AMERICAN WATER WORKS CO INC | $4,187,000 | +29.7% | 28,900 | +15.1% | 0.08% | +17.1% |
| CWEN | New | CLEARWAY ENERGY INCcl c | $4,047,000 | – | 150,100 | +100.0% | 0.08% | – |
| SHW | Buy | SHERWIN WILLIAMS CO | $3,762,000 | +32.9% | 5,400 | +10.2% | 0.07% | +19.4% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $3,785,000 | +49.6% | 27,800 | +31.1% | 0.07% | +34.5% |
| EXACT SCIENCES CORPnote 1.000% 1/1 | $3,743,000 | +13.3% | 2,411,000 | 0.0% | 0.07% | +1.4% | ||
| EQIX | Sell | EQUINIX INC | $3,573,000 | -4.0% | 4,700 | -11.3% | 0.07% | -13.6% |
| AMWL | New | AMERICAN WELL CORPcl a added | $3,263,000 | – | 110,091 | +100.0% | 0.06% | – |
| Buy | NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $2,963,000 | +63.0% | 2,139,000 | +96.8% | 0.06% | +45.0% | |
| ZTS | Buy | ZOETIS INCcl a | $2,911,000 | +49.6% | 17,600 | +23.9% | 0.06% | +35.7% |
| SYY | New | SYSCO CORP | $2,296,000 | – | 36,900 | +100.0% | 0.04% | – |
| WM | Sell | WASTE MGMT INC DEL | $2,320,000 | -38.8% | 20,500 | -42.7% | 0.04% | -45.1% |
| FHN | Sell | FIRST HORIZON NATL CORP | $2,054,000 | -36.4% | 217,800 | -32.8% | 0.04% | -42.9% |
| SNPS | New | SYNOPSYS INC | $1,977,000 | – | 9,238 | +100.0% | 0.04% | – |
| DPZ | New | DOMINOS PIZZA INC | $1,999,000 | – | 4,700 | +100.0% | 0.04% | – |
| IEX | Buy | IDEX CORP | $2,007,000 | +71.7% | 11,000 | +48.6% | 0.04% | +56.0% |
| ETTX | ENTASIS THERAPEUTICS HLDGS I | $1,705,000 | -31.1% | 879,541 | 0.0% | 0.03% | -38.9% | |
| MSCI | Buy | MSCI INC | $1,606,000 | +33.6% | 4,500 | +25.0% | 0.03% | +19.2% |
| TSM | New | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $1,475,000 | – | 18,200 | +100.0% | 0.03% | – |
| IMTXW | New | IMMATICS N.V*w exp 07/01/202 added | $1,380,000 | – | 400,000 | +100.0% | 0.03% | – |
| LSCC | New | LATTICE SEMICONDUCTOR CORP | $700,000 | – | 24,169 | +100.0% | 0.01% | – |
| OM | New | OUTSET MED INC | $682,000 | – | 13,636 | +100.0% | 0.01% | – |
| DOCU | New | DOCUSIGN INC | $630,000 | – | 2,925 | +100.0% | 0.01% | – |
| SLAB | New | SILICON LABORATORIES INC | $427,000 | – | 4,368 | +100.0% | 0.01% | – |
| AMD | New | ADVANCED MICRO DEVICES INC | $337,000 | – | 4,108 | +100.0% | 0.01% | – |
| OSH | New | OAK STR HEALTH INC | $267,000 | – | 5,000 | +100.0% | 0.01% | – |
| ELS | Exit | EQUITY LIFESTYLE PPTYS INC | $0 | – | -4,900 | -100.0% | -0.01% | – |
| BRBR | Exit | BELLRING BRANDS INC | $0 | – | -28,000 | -100.0% | -0.01% | – |
| Exit | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $0 | – | -384,000 | -100.0% | -0.02% | – | |
| NDAQ | Exit | NASDAQ INC | $0 | – | -7,700 | -100.0% | -0.02% | – |
| AQN | Exit | ALGONQUIN PWR UTILS CORP | $0 | – | -148,200 | -100.0% | -0.04% | – |
| ARYAW | Exit | ARYA SCIENCES ACQUISITION CO*w exp 10/10/202 | $0 | – | -400,000 | -100.0% | -0.05% | – |
| WEC | Exit | WEC ENERGY GROUP INC | $0 | – | -30,900 | -100.0% | -0.06% | – |
| TCF | Exit | TCF FINANCIAL CORPORATION NE | $0 | – | -93,200 | -100.0% | -0.06% | – |
| CMS | Exit | CMS ENERGY CORP | $0 | – | -53,100 | -100.0% | -0.07% | – |
| TER | Exit | TERADYNE INC | $0 | – | -44,600 | -100.0% | -0.08% | – |
| ARYA | Exit | ARYA SCIENCES ACQUISITION CO | $0 | – | -800,000 | -100.0% | -0.27% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -45,500 | -100.0% | -0.29% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -1,543,000 | -100.0% | -0.34% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -500,000 | -100.0% | -0.49% | – |
| STSA | Exit | SATSUMA PHARMACEUTICALS INC | $0 | – | -983,382 | -100.0% | -0.62% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -1,211,300 | -100.0% | -0.71% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -1,212,000 | -100.0% | -0.88% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -3,193,117 | -100.0% | -1.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.